Company / Operating Cash Flow
Annexon, Inc. Operating Cash Flow History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$118.0M
FY2024
5-year range
-$121.1M / -$53.1M
FY2020-FY2024
Trend
+2.6%
vs FY2023
Sector context
#129 of 214
Health Care
What the data says
At -$118M, Annexon, Inc.'s operating cash flow ranks #129 of 214 in the Health Care sector. Operating Cash Flow returned to growth in FY2024 after 4 years of decline, reaching -$118M.
Based on SEC 10-K filings.
-$118M in FY2024.
Remained stable around -$118M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#129 of 214 in Health CareTop 60% of 214This company -$118.0M Sector average $663.6M
▼
-117.8% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow increased 2.6% year-over-year.
- Ranks #129 out of 214 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2019.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$118.0M | +2.6% |
| FY2023 | -$121.1M | -4.2% |
| FY2022 | -$116.3M | -9.6% |
| FY2021 | -$106.1M | -99.9% |
| FY2020 | -$53.1M | -87.2% |
| FY2019 | -$28.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026